The FTC is increasingly unlikely to block the Express Scripts (ESRX +1.8%)/Medco (MHS +1.7%)...


The FTC is increasingly unlikely to block the Express Scripts (ESRX +1.8%)/Medco (MHS +1.7%) deal, reports the WSJ. It's not a surprise, but the stocks get a nice pop on the news.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs